Related Experiment Video

Updated: Jun 2, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology
03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Clinical trials and treatment of the elderly diagnosed with ovarian cancer

Gilles Freyer1, Anna V Tinker,

  • 1Department of Medical Oncology, Lyon University, Hospices Civils de Lyon, Pierre-Bénite Cédex, France.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|May 6, 2011
PubMed

Insights

Elderly patients with advanced ovarian cancer are underrepresented in clinical trials, leading to a knowledge gap in their appropriate assessment and treatment. This review summarizes current data and highlights future research needs for this population.

Area of Science:

  • Gynecologic Oncology
  • Geriatric Medicine
  • Clinical Trial Research

Background:

  • Elderly patients increasingly represent a larger proportion of advanced ovarian cancer diagnoses.
  • Historically, older adults have been underrepresented in clinical trials for ovarian cancer.
  • This underrepresentation limits understanding of optimal assessment and treatment strategies for elderly ovarian cancer patients.

Purpose of the Study:

  • To summarize existing data on the assessment and treatment of advanced ovarian cancer in elderly patients.
  • To identify critical knowledge gaps and future research directions in this field.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of clinical trial data concerning elderly ovarian cancer patients.
  • Identification of trends and disparities in care.

Main Results:

  • Data on the specific needs and outcomes of elderly ovarian cancer patients in clinical trials are scarce.
  • Current treatment guidelines may not adequately address the unique physiological and comorbidity considerations of older adults.
  • Significant gaps exist in understanding optimal diagnostic and therapeutic approaches.

Conclusions:

  • There is a pressing need to increase the inclusion of elderly patients in ovarian cancer clinical trials.
  • Further research is essential to develop evidence-based guidelines for the assessment and treatment of ovarian cancer in older adults.
  • Addressing these research gaps will improve care and outcomes for the growing elderly population diagnosed with ovarian cancer.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...